Sheryl Kluberg, PhD, SM

Dr. Sheryl Kluberg is a Research Scientist in the Department of Population Medicine at the Harvard Pilgrim Health Care Institute, with expertise using administrative claims data to address complex public health and regulatory research questions. She leads studies on drug and vaccine safety and effectiveness, contributing to post-market regulatory efforts in collaboration with the U.S. Food and Drug Administration and industry sponsors. Her work also includes validating claims-based algorithms for identifying key health outcomes and evaluating their use in national disease surveillance.

Dr. Kluberg received an SM in Epidemiology from the Harvard School of Public Health and a PhD in Epidemiology from the Boston University School of Public Health, where her research focused on infectious disease, disease surveillance, and quasi-experimental study design.